WO2008069518A1 - Composition pharmaceutique pour réguler la fonction de la sphingosylphosphorylcholine - Google Patents

Composition pharmaceutique pour réguler la fonction de la sphingosylphosphorylcholine Download PDF

Info

Publication number
WO2008069518A1
WO2008069518A1 PCT/KR2007/006188 KR2007006188W WO2008069518A1 WO 2008069518 A1 WO2008069518 A1 WO 2008069518A1 KR 2007006188 W KR2007006188 W KR 2007006188W WO 2008069518 A1 WO2008069518 A1 WO 2008069518A1
Authority
WO
WIPO (PCT)
Prior art keywords
yloxy
naphthalene
acetamide
ethyl
amine
Prior art date
Application number
PCT/KR2007/006188
Other languages
English (en)
Inventor
Jaeyoung Ko
Hyuk Kim
Kwang Mi Kim
Minsoo Noh
Chang-Hoon Lee
Jung Ju Kim
Hyoung June Kim
Sun A Cho
Ki Sa Sung
Dae-Kwon Kim
Jae-Min Shin
Doo Ho Cho
Sanghee Kim
Chaemin Lim
Original Assignee
Amorepacific Corporation
Sbscience Inc.
Seoul National University Industry Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amorepacific Corporation, Sbscience Inc., Seoul National University Industry Foundation filed Critical Amorepacific Corporation
Publication of WO2008069518A1 publication Critical patent/WO2008069518A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne une nouvelle utilisation de dérivés de naphtalènyloxyprophénylhydroxybenzamide d'alkylcarbamoyle pour réguler la fonction de la sphingosylphosphorylcholine.
PCT/KR2007/006188 2006-12-08 2007-12-03 Composition pharmaceutique pour réguler la fonction de la sphingosylphosphorylcholine WO2008069518A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20060124245 2006-12-08
KR10-2006-0124245 2006-12-08

Publications (1)

Publication Number Publication Date
WO2008069518A1 true WO2008069518A1 (fr) 2008-06-12

Family

ID=39492338

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2007/006188 WO2008069518A1 (fr) 2006-12-08 2007-12-03 Composition pharmaceutique pour réguler la fonction de la sphingosylphosphorylcholine

Country Status (1)

Country Link
WO (1) WO2008069518A1 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004089470A2 (fr) * 2003-04-11 2004-10-21 Novo Nordisk A/S Utilisation pharmaceutique d'amides substitues
WO2005014777A2 (fr) * 2002-10-16 2005-02-17 Board Of Regents, The University Of Texas System Procedes et compositions pour augmenter l'efficacite de substances actives d'un point de vue biologique
US20060167263A1 (en) * 2005-01-21 2006-07-27 Wilde Richard G Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease
WO2006091246A1 (fr) * 2004-11-01 2006-08-31 University Of Southern California Nouveaux composes utiles pour le traitement du cancer et des troubles associes a la fonction d'angiogenese
WO2006117305A1 (fr) * 2005-05-04 2006-11-09 F. Hoffmann-La Roche Ag (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines exerçant une activite sur le recepteur 5-ht
WO2007136159A1 (fr) * 2006-05-18 2007-11-29 Amorepacific Corporation Utilisation d'antagoniste de sphingosylphosphorylcholine pour restaurer l'expression de peptides antimicrobiens

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005014777A2 (fr) * 2002-10-16 2005-02-17 Board Of Regents, The University Of Texas System Procedes et compositions pour augmenter l'efficacite de substances actives d'un point de vue biologique
WO2004089470A2 (fr) * 2003-04-11 2004-10-21 Novo Nordisk A/S Utilisation pharmaceutique d'amides substitues
WO2006091246A1 (fr) * 2004-11-01 2006-08-31 University Of Southern California Nouveaux composes utiles pour le traitement du cancer et des troubles associes a la fonction d'angiogenese
US20060167263A1 (en) * 2005-01-21 2006-07-27 Wilde Richard G Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease
WO2006117305A1 (fr) * 2005-05-04 2006-11-09 F. Hoffmann-La Roche Ag (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines exerçant une activite sur le recepteur 5-ht
WO2007136159A1 (fr) * 2006-05-18 2007-11-29 Amorepacific Corporation Utilisation d'antagoniste de sphingosylphosphorylcholine pour restaurer l'expression de peptides antimicrobiens

Similar Documents

Publication Publication Date Title
DE60215919T2 (de) 4-fluoro-n-indan-2-yl benzamid und seine verwendung als arzneimittel
EP1378247B1 (fr) Agents pour le traitement de maladies de la function visuelle
EP0043807B1 (fr) Dérivés du 1-(dihydroxyphényl)-2-amino éthanol; préparation, compositions et intermédiaires
EP2139325B1 (fr) Bithionol comme agent anti-angiogénique
AU2006275824B2 (en) Method of improving wakefulness
KR101891986B1 (ko) 트랜스-2-데센산 유도체 및 이것을 함유하는 의약
US20230052152A1 (en) Compounds for treatment of alzheimer's disease
JP2009538827A (ja) カンナビノイドおよび使用方法
WO2008069518A1 (fr) Composition pharmaceutique pour réguler la fonction de la sphingosylphosphorylcholine
JP2013514379A (ja) 神経障害の治療のための化合物
WO2009042485A1 (fr) Composés de type indole porteur de groupes hétéroaryles ayant une activité biologique de récepteur de la sphingosine-1-phosphate (s1p)
CN113387909B (zh) 2,3-环氧丁二酰衍生物的医药用途
WO2009069966A2 (fr) Utilisation de composés pour contrôler la fonction de la sphingosylphosphorylcholine
KR102322349B1 (ko) 척수 손상 또는 척추관 협착증의 예방 또는 치료용 약제학적 조성물
JP2779269B2 (ja) 不整脈治療におけるジアミン
KR100879411B1 (ko) 스핑고실포스포릴콜린의 작용을 억제하는 약학 조성물
KR102563719B1 (ko) S1pr1과 s1pr4에 대한 기능적 저해제로 작용하는 ifta 예방 또는 치료용 약학적 조성물
JP2006519223A (ja) ２，２，３，３−テトラメチルシクロプロパンカルボン酸の新規アミド誘導体
WO2003022266A1 (fr) Hypoestoxides, derives et agonistes de ceux-ci utilises comme inhibiteurs d'angiogenese
JP2020203859A (ja) ミトコンドリア膜透過性遷移孔（ｍＰＴＰ）の開口阻害剤、ｍＰＴＰ開口阻害活性を有する新規化合物及びそれらの用途
JP2587803B2 (ja) カルシウム拮抗剤
JP2010132637A (ja) 炎症関連疾患治療剤用２，４−二重置換−５−アミノカルボニル−１，３−チアゾール誘導体、その製造方法及びそれを有効成分として含有するｓｐｃ受容体活性により誘発される炎症関連疾患の治療剤、外傷後傷跡形成抑制及び傷治癒促進用皮膚外用剤、腫瘍内部の血管新生阻害剤
OA21243A (en) Compounds for treatment of alzheimer's disease.
JP2013241408A (ja) トランス−２−デセン酸誘導体を含有する医薬
WO2009085847A1 (fr) Tétrahydroxyindoles agissant sur l'activité du récepteur du sphingosine-1-phosphate

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07851180

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07851180

Country of ref document: EP

Kind code of ref document: A1